Solventum Corp (FRA:KB7)
€ 65 -2 (-2.99%) Market Cap: 11.43 Bil Enterprise Value: 15.58 Bil PE Ratio: 9.21 PB Ratio: 2.63 GF Score: 26/100

Solventum Corp at KeyBanc Healthcare Forum Transcript

Mar 18, 2026 / 02:30PM GMT
Release Date Price: €58.8 (+2.80%)
Brett Fishbin
KeyBanc Capital Markets Inc - Equity Analyst

All right, I'd like to welcome everyone back to the day two of the sixth annual [KBCM] Healthcare Forum. My name is Brett Fishbin, Senior Med Tech Analyst, and I'm pleased to be joined this morning by Saul Bentham, who's represented today by Bryan Hanson, the Chief Executive Officer; Wayde McMillan, the CFO; and Amy Wakem, SVP of Investor Relations.

This will be a 100% Q&A session. Questions can be submitted below the video screen, and time permitting. We'll relay to management, but I'll kick things off. So Bryan, you've been CEO at Solventum now for over two years.

It's been a super eventful period, thinking about the original separation from 3M, you defined a new machine. Upgraded talent across the organization started -- thinking about portfolio management, as well as acquisitions.

So I was just hoping we could kick things off with, some high level thoughts just how you feel, solventum is in regards to standing the company up some what some of the biggest accomplishments have been, and then, your key priorities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot